insights_auto
Why is BOT up 25.00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
arrow_upward
+25.00%(+0.0020) 1D
Nov 17, 4:10:06 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.10M
Avg. vol.
10.87M
Volume
10.30M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.10M
Avg. vol.
10.87M
Volume
10.30M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
TradingView
·
1 hour ago
Dow Plunges 700 Points as S&P 500 and Nasdaq Fall Ahead of Nvidia Earnings
BigGo Finance
·
2 hours ago
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
ChartMill
·
2 hours ago
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
Traders Union
·
2 hours ago
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com